Andra AP-fonden’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.69M Sell
20,627
-10,110
-33% -$3.57M 0.09% 238
2026
Q2
$11M Sell
30,737
-24,270
-44% -$7.42M 0.13% 196
2026
Q1
$13.8M Buy
55,007
+48,327
+723% +$12M 0.16% 154
2025
Q4
$1.84M Buy
+6,680
New +$1.83M 0.02% 366
2024
Q4
– Sell
-26,000
Closed -$7.8M – 465
2024
Q3
$7.8M Buy
26,000
+1,000
+4% +$306K 0.11% 258
2024
Q2
$8.23M Buy
25,000
+4,700
+23% +$1.66M 0.14% 233
2024
Q1
$8.03M Buy
+20,300
New +$7.51M 0.14% 220
2023
Q3
– Sell
-25,200
Closed -$9.6M – 575
2023
Q2
$9.6M Sell
25,200
-500
-2% -$179K 0.24% 120
2023
Q1
$8.9M Sell
25,700
-18,200
-41% -$5.32M 0.23% 155
2022
Q4
$10.3M Buy
43,900
+3,500
+9% +$829K 0.31% 49
2022
Q3
$9.9M Buy
40,400
+5,900
+17% +$1.8M 0.33% 53
2022
Q2
$10.4M Buy
34,500
+300
+0.9% +$97.6K 0.3% 69
2021
Q4
$16M Sell
34,200
-300
-0.9% -$129K 0.33% 48
2021
Q3
$14.6M Buy
34,500
+3,000
+10% +$1.26M 0.3% 53
2021
Q2
$11.3M Sell
31,500
-1,000
-3% -$330K 0.23% 130
2021
Q1
$9.16M Sell
32,500
-16,200
-33% -$4.64M 0.2% 209
2020
Q4
$13.8M Sell
48,700
-3,500
-7% -$982K 0.3% 32
2020
Q3
$14.4M Buy
52,200
+7,800
+18% +$2.06M 0.39% 6
2020
Q2
$10.1M Buy
44,400
+11,600
+35% +$2.28M 0.29% 15
2020
Q1
$4.99M Sell
32,800
-5,800
-15% -$893K 0.18% 185
2019
Q4
$5.8M Buy
+38,600
New +$5.62M 0.17% 286

Other funds holding WST

Andra AP-fonden's WST Position: Q3 2026 in Review

Andra AP-fonden reduced its West Pharmaceutical (WST) stake by 33% in Q3 2026, selling an estimated $3.57M and leaving 20,627 shares worth $7.69M. The position accounts for 0.09% of the portfolio, ranked #238.

Andra AP-fonden first reported a position in WST in Q4 2019 and has held it in 21 quarters since. The position peaked at $16M in Q4 2021. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Andra AP-fonden held 20,627 shares of West Pharmaceutical worth $7.69M as of Q3 2026.
  • Andra AP-fonden sold 10,110 West Pharmaceutical shares in Q3 2026, an estimated $3.57M.
  • West Pharmaceutical made up 0.09% of Andra AP-fonden's portfolio in Q3 2026, its #238 holding.
  • Andra AP-fonden first reported a position in West Pharmaceutical in Q4 2019 and has held it in 21 quarters since.
  • Andra AP-fonden's West Pharmaceutical position peaked at $16M in Q4 2021.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Andra AP-fonden's 13F filing for Q3 2026, filed 13 Nov 2026.